China Biologic Products Holdings Inc (CBPO)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

18TH FL, JIALONG INTERNATIONALBUILDING BEIJING, CHINA 100125

China Biologic Products Holdings, Inc. operates as a biopharmaceutical company. The Company researches, develops, and produces human plasma-based pharmaceutical and coagulation factor products in the form of tablets, injections, capsules, and syrups. China Biologic Products also distributes pharmaceutical products. China Biologic Products serves clients in China.

Data as of 2020-08-01
Market Cap4.092 Billion Shares Outstanding38.481 Million Avg 30-day Volume115.985 Thousand
P/E Ratio26.9 Dividend Yield EPS3.95
Price/Sales10.209 Price cash flow ratio15.1 Price free cash flow ratio20.6
Book Value45.11 Price to Tangible Book2.94 Alpha-0.0
Short Interest Ratio % Short Interest to Float R-squared0.122796
BETA0.816382 52-week High/Low119.44 / 92.22 Stddev0.100235
View SEC Filings from CBPO instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 7 4 (0.26%)
13F Filers holding this stock: 84 24 (1.57%)
Aggregate 13F shares on 03/31/2020: 11.464 Million 6.167 Million
Aggregate 13F shares on 12/31/2019: 11.042 Million 5.484 Million
Percent change: 3.82% 12.45%
Funds creating new positions: 15 5
Funds Adding to an existing position: 27 11
Funds closing out their position: 18 9
Funds reducing their position: 27 6
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CBPO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CBPO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KITT BARRY M

  • 10% Owner
2,000,000 2020-08-05 0

CUI XIANGMIN

  • Director
  • 10% Owner
0 2020-01-02 0

KUO YUYUN TRISTAN CHIEF FINANCIAL OFFICER

  • Officer
0 2019-12-31 0

LIU ZHIJING CBPO CORPORATE VICE PRESIDENT

  • Officer
4,611 2017-05-08 0

SHAO SEAN

  • Director
20,000 2017-03-01 0

GAO DAVID CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
395,347 2017-02-28 0

YEUNG ALBERT

  • Director
45,000 2016-12-09 0

LIU WENFANG

  • Director
3,383 2016-08-15 0

YANG MING CHIEF FINANCIAL OFFICER

  • Officer
24,782 2016-08-15 0

YIN MING SR. CORPORATE VICE PRESIDENT

  • Officer
16,467 2016-08-15 0

YANG GANG CBPO CORPORATE VICE PRESIDENT

  • Officer
32,242 2016-08-15 0

LI DAVID HUI

  • Director
269 2016-08-11 0

FANG MIN

  • Director
7,417 2016-08-11 0

LU YUNGANG

  • Director
18,000 2016-08-04 0

TONG ZHIJUN

  • Director
12,000 2016-08-04 0

CHOW JOSEPH

  • Director
10,000 2016-08-04 0

WP X BIOLOGICS LLC

WARBURG PINCUS PRIVATE EQUITY X, L.P.

WARBURG PINCUS X PARTNERS, L.P.

WARBURG PINCUS X, L.P.

WARBURG PINCUS X GP L.P.

WPP GP LLC

WARBURG PINCUS PARTNERS, L.P.

WARBURG PINCUS PARTNERS GP LLC

WARBURG PINCUS & CO.

WARBURG PINCUS LLC

  • Director
  • 10% Owner
No longer subject to file 2016-06-08 0

WP X BIOLOGICS LLC

KAYE CHARLES R

LANDY JOSEPH P.

  • Director
  • 10% Owner
No longer subject to file 2016-06-08 0

WARBURG PINCUS PRIVATE EQUITY X, L.P.

WARBURG PINCUS X, L.P.

WARBURG PINCUS X PARTNERS, L.P.

WARBURG PINCUS X LLC

WARBURG PINCUS PARTNERS LLC

WARBURG PINCUS & CO.

WARBURG PINCUS LLC

KAYE CHARLES R

LANDY JOSEPH P.

  • 10% Owner
No longer subject to file 2014-08-12 0

FENG DAI

  • Director
10,989,200 2014-05-04 0

LI BING

  • Director
5,000 2013-08-16 0

ZHANG LE

  • Director
5,000 2013-08-16 0

LI LIN LING

  • SEE REMARKS
No longer subject to file 2013-05-14 0

WP X BIOLOGICS LLC

WARBURG PINCUS PRIVATE EQUITY X, L.P.

WARBURG PINCUS X PARTNERS, L.P.

WARBURG PINCUS X, L.P.

WARBURG PINCUS X LLC

WARBURG PINCUS PARTNERS LLC

WARBURG PINCUS & CO.

WARBURG PINCUS LLC

KAYE CHARLES R

LANDY JOSEPH P.

  • Director
  • 10% Owner
10,989,200 2013-05-14 0

ZHAO CHAO MING PRESIDENT

  • Officer
621,787 2012-11-28 0

ZHANG HAN

  • Director
0 2012-04-20 0

LIN TONG JUN

  • Director
0 2011-01-01 0

LI CHONG YANG

  • Director
0 2010-12-17 0

CHAN LING SIU

  • Director
  • 10% Owner
5,362,624 2010-12-13 0

GAN JIE

  • Director
0 2008-07-24 0

WONG CBPO STANLEY CHIEF EXECUTIVE OFFICER

  • Officer
0 2008-05-09 0

PANG GUANG LI

  • Director
0 2008-05-09 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments